Related Experiment Video
Updated: May 16, 2026

Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer
Published on: September 18, 2020
Promoter and histone methylation and p16(INK4A) gene expression in colon cancer
Ebru Esin Yoruker1, Ufuk Mert, Dursun Bugra
1Department of Basic Oncology, Oncology Institute and.
Abstract:
The inactivation of the cyclin-dependent kinase inhibitor p16(INK4A) gene by hypermethylation is observed in numerous types of cancer. New findings indicate that DNA and histone methylation act in concert in gene silencing. In this study, we investigated the methylation status of the p16(INK4A) gene promoter and the histone 3 lysine 9 residue in the tumors and matched normal tissue samples from patients with colorectal cancer and analyzed their association with gene expression. The methylation and expression of the p16(INK4A) gene were analyzed by real-time PCR, and histone methylation was analyzed by chromatin immunoprecipitation followed by real-time PCR. p16(INK4A) expression was significantly higher in the tumors compared to normal tissue. Mono-, di- and trimethylation levels of the H3K9 residue were similar in the tumor and normal tissue samples. We did not observe any significant correlation between p16(INK4A) methylation or expression and clinical parameters. Our results suggest that epigenetic modifications of the p16(INK4A) gene and histone lysine methylation do not play a major role in colon carcinogenesis.
Insights
Epigenetic silencing of the p16(INK4A) gene via DNA methylation is common in cancer. However, this study found no significant correlation between p16(INK4A) methylation, histone modifications, and colorectal cancer development.
Area of Science:
- Oncology
- Epigenetics
- Molecular Biology
Background:
- The cyclin-dependent kinase inhibitor p16(INK4A) gene is frequently inactivated by hypermethylation in various cancers.
- Emerging evidence suggests that DNA and histone methylation cooperate in gene silencing mechanisms.
- Understanding these epigenetic alterations is crucial for cancer research.
Purpose of the Study:
- To investigate the methylation status of the p16(INK4A) gene promoter in colorectal cancer.
- To analyze the methylation levels of histone 3 lysine 9 (H3K9) in tumor and normal tissues.
- To assess the association between p16(INK4A) methylation, histone methylation, and gene expression in colorectal cancer.
Main Methods:
- Real-time PCR was used to analyze p16(INK4A) gene methylation and expression.
- Chromatin immunoprecipitation followed by real-time PCR (ChIP-PCR) was employed to assess histone H3K9 methylation.
- Tumor and matched normal tissue samples from colorectal cancer patients were utilized.
Main Results:
- p16(INK4A) gene expression was significantly elevated in tumor tissues compared to normal tissues.
- Levels of mono-, di-, and trimethylation of the H3K9 residue were comparable between tumor and normal samples.
- No significant correlation was found between p16(INK4A) methylation or expression and clinical parameters.
Conclusions:
- Epigenetic modifications of the p16(INK4A) gene promoter do not appear to be a major driver in colon carcinogenesis.
- Histone lysine methylation at H3K9 is unlikely to play a significant role in the development of colorectal cancer.
- Further research may be needed to explore other epigenetic mechanisms in colorectal cancer.
Related Concept Videos
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
Abnormal Proliferation
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Histone Modification
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone deacetylase,...
Histone Modification
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone deacetylase,...
